FY13 results on Feb 18, 2014

| Updated on January 29, 2014 Published on January 29, 2014

GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 18, 2014, inter-alia, to consider amongst other things, approval of audited financial results for the year ended December 31, 2013 and to recommend dividend, if any, on the equity shares of the Company.

Source : BSE - >

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on January 29, 2014
This article is closed for comments.
Please Email the Editor